VIDEO: SABCS 2017 roundtable with Dr. Hope S. Rugo and Dr. William J. GradisharDecember 13, 2017Breast Cancer
CDK4/6 inhibitors have similar efficacy in older breast cancer patientsDecember 12, 2017Breast Cancer
PANACEA: pembrolizumab overcomes trastuzumab resistance for someDecember 11, 2017Breast CancerImmuno-oncology
Novel PARP inhibitor boosts PFS in HER2- breast cancer with BRCA mutationsDecember 11, 2017Breast Cancer
Extra years of adjuvant bisphosphonate not needed in early breast cancerDecember 11, 2017Breast CancerPatient & Survivor Care
VIDEO: Novel PARP inhibitor boosts PFS in HER2– breast cancer with BRCA mutationsDecember 9, 2017Breast Cancer
Ovarian suppression during breast cancer chemo helps stave off early menopause, preserve fertilityDecember 9, 2017Breast CancerPatient & Survivor Care
Adjuvant trastuzumab for 1 year remains standard of care for early HER2+ breast cancerDecember 8, 2017Breast Cancer
2 = 5 for additional AI therapy for postmenopausal HR+ breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
VIDEO: CDK4/6, ET, LHRH combo improves PFS in premenopausal breast cancerDecember 8, 2017Breast Cancer
Acupuncture significantly reduces AI-associated arthralgiasDecember 8, 2017Breast CancerPatient & Survivor Care
VIDEO: 5 years of additional AI no better than 2 in HR+ breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
